Eculizumab

Details

Files

Generic Name:

Eculizumab

Project Status:

Complete

Therapeutic Area:

Paroxysmal nocturnal hemoglobinuria (PNH)

Manufacturer:

Alexion Pharmaceuticals Inc.

Brand Name:

Soliris

Project Line:

Reimbursement Review

Project Number:

SR0176-000

Submission Type:

Initial

Indications:

Paroxysmal nocturnal hemoglobinuria (PNH)

Recommendation Type:

Do not list

Final Recommendation:

February 18, 2010

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : September 18, 2009